SU2C Hosts Experts in Cancer Detection and Vaccines at New York Genome Center

Stand Up To Cancer convened a group of top experts to discuss cancer detection platforms, their role in survival and relapse, and how vaccines can be a potential solve in the interception of cancer.

In attendance were top luminaries, who spoke to detection platforms and vaccines, including Lisa Butterfield, Ph.D., Merck & Co, Inc.; Paul Billings, M.D., Ph.D., Biological Dynamics; Christelle Johnson, Ph.D., Personalis; Gitte Pedersen, Genomic Expressions; Michael Milburn, Ph.D., GeneCentric Therapeutics; Dan Landau, M.D., Ph.D., Weill Cornell Medical College, New York Genome Center; Bernard Peperstraete, M.D., AcuamarkDx; Diane Simeone, M.D., Moores Cancer Center, UC San Diego Health; Connie Trimble, M.D., Johns Hopkins University; Mark DeMario, M.D., MPH, BioNTech; Karin Jooss, Ph.D., Griststone bio; Niranjan Sardesai, Ph.D., Geneos Therapeutics; Morena D’Alise, Ph.D., Nouscom; Peter DeMuth, Ph.D., Elicio Therapeutics; Stephen Schoenberger, Ph.D., La Jolla Institute for Immunology; Tim Elliott, Ph.D., University of Oxford.

Our Mission

Stand Up To Cancer raises awareness and funds research to detect and treat cancers with the aspiration to cure all patients.

  • Impact at a Glance

    Doctor and patient holding placards showcasing their support for groups affected by cancer.
    0+
    INSTITUTIONS
    0+
    RESEARCHERS
    0+
    CLINICAL TRIALS
    0+
    RESEARCH TEAMS
    0+
    CLINICAL TRIAL PATIENTS

  • Fund Research. Donate!

    Stand Up To Cancer is a leader in innovative cancer research, bringing together the best and brightest to create new groundbreaking therapies and treatments.

    Secure Payment

Related Stories